trending Market Intelligence /marketintelligence/en/news-insights/trending/Nhhj4DpdGem-QsI2_QY7pA2 content esgSubNav
In This List

ASX reinstates Bod Australia to official quotation

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


ASX reinstates Bod Australia to official quotation

Natural medicines distributor Bod Australia Ltd said Dec. 8 that it has been reinstated to official quotation on the Australian Stock Exchange after the bourse determined that the company's medicinal cannabis activities do not constitute a change to the nature or scale of its activities.

The lifting of the suspension came three days after the ASX approved the company's request for voluntary trading suspension while awaiting the exchange's decision on its application of chapter 11 of the ASX listing rules to its proposed medicinal cannabis activities.

In the same week, Bod was granted a medicinal cannabis import license, allowing it to store and supply medicinal cannabis products and establish medical cannabis operations in Australia.